
Formerly CaPCURE, the Prostate Cancer Foundation (PCF) is the world's largest philanthropic source of support for prostate cancer research. The PCF has a single goal: To find better treatments and a cure for recurrent prostate cancer. The PCF, a 501(c)(3) organization, pursues its mission by reaching out to individuals, corporations and others to harness society.s resources. financial and human.to fight this deadly disease.
Founded in 1993, the PCF has raised more than $320 million and provided funding to more than 1,400 researchers at nearly 150 institutions worldwide. The PCF has been a pioneer in the grant making process, simplifying paperwork for grantees, leaving more time for researchers to conduct needed scientific research. The PCF also advocates for greater awareness of prostate cancer and more governmental resources, resulting in a 20-fold increase in government funding for prostate cancer.
In addition, the PCF.s Scientific Retreat convenes leading cancer researchers, physicians, government officials, the biopharmaceutical industry and others each year to discuss new developments and remove barriers that impede progress.
> About PCF
> Where Your Money Goes
> Home Run Foundation
> PCF Thank You Letter
The mission of the Cystic Fibrosis Foundation, a nonprofit donor-supported organization, is to assure the development of the means to cure and control cystic fibrosis and to improve the quality of life for those with the disease.
The Foundation is the leading organization in the United States devoted to cystic fibrosis. It funds and accredits more than 115 CF care centers, 95 adult care programs and 50 affiliate programs, and has 80 fund-raising chapters and branch offices nationwide.
The Cystic Fibrosis Foundation is one of the most efficient organizations of its kind. In 2007, 90 percent of every dollar of revenue raised was available to fund cystic fibrosis research, care and education programs.
JDRF is the leading charitable funder and advocate of type 1 (juvenile) diabetes research worldwide. The mission of JDRF is to find a cure for diabetes and its complications through the support of research. Type 1 diabetes is a disease which strikes children suddenly and requires multiple injections of insulin daily or a continuous infusion of insulin through a pump. Insulin, however, is not a cure for diabetes, nor does it prevent its eventual and devastating complications, which may include kidney failure, blindness, heart disease, stroke, and amputation. Since 1970, JDRF has awarded more than $1.4 billion to diabetes research, including more than $100 million in 22 countries in FY2009.



